Coronary Thrombosis
Coronary Thrombosis - Related Videos
10:37
Ferric Chloride-induced Murine Thrombosis Models
0 Views •
Cited by 56 •
2016
We report a refined procedure of the ferric chloride (FeCl3)-induced thrombosis models on carotid and mesenteric artery as well as vein, characterized efficiently using intravital microscopy to monitor time to occlusive thrombi formation.
10:26
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
0 Views •
Cited by 5 •
2015
The goal of this study is to use magnetic resonance venography with long-circulating gadolinium-based contrast agent and direct thrombus imaging for quantitative evaluation of DVT volume in a multicenter, clinical trial setting. Inter- and intra-observer variability assessments were conducted, and reproducibility of the protocol was determined.
06:39
Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
0 Views •
Cited by 20 •
2015
Coronary flow reserve (CFR) is useful for assessment of myocardial oxygen demand and evaluation of cardiovascular risk. This study establishes a step-by-step transthoracic Doppler echocardiographic (TTDE) method for longitudinal monitoring of the changes in CFR, as measured from coronary artery in mice, under the experimental pressure overload of aortic banding.
04:34
Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
0 Views •
Cited by 28 •
2011
The mouse complete stasis model of inferior vena cava thrombosis yields quantifiable amounts of vein wall tissue and thrombus. It has proven useful for evaluating interactions between the vein wall and the occlusive thrombus and in assessing the progression from acute to chronic inflammation.
07:36
Isolation of Mouse Coronary Endothelial Cells
0 Views •
Cited by 18 •
2016
This protocol is prepared to share our method of isolating mouse coronary endothelial cells for the purpose of imaging or to conduct molecular biological experiments.
FAQs
Plaque rupture or erosion exposes thrombogenic material to circulating blood. This exposure activates platelets at the damaged site and initiates the coagulation cascade. Fibrin then stabilizes the developing platelet-rich clot, allowing it to become more persistent and capable of restricting blood flow through the affected coronary artery.
The clinical effect depends on how the clot interferes with blood flow to the heart muscle. As obstruction develops, perfusion can become inadequate, producing myocardial ischemia and potentially myocardial infarction. This link between clot formation and impaired oxygen delivery explains why coronary thrombosis is central to acute coronary syndromes.
These treatments target different parts of clot formation. Antiplatelet strategies act on platelet activation, whereas anticoagulant strategies address the coagulation cascade that produces fibrin. Using this mechanistic distinction helps clinicians choose approaches intended to limit clot growth, while also supporting treatment decisions aimed at restoring coronary perfusion.
Recognition begins with prompt attention to possible ischemic symptoms, followed by diagnostic testing. The resulting clinical and diagnostic information helps determine whether an acute coronary syndrome may be present and guides decisions about restoring perfusion or limiting further clot growth. Rapid evaluation is therefore an important part of medical management.
Management focuses on two related objectives: restoring blood flow to the heart muscle and limiting additional clot development. Medical decisions may include antiplatelet or anticoagulant strategies, selected according to the thrombotic mechanisms involved. The purpose is to reduce the effect of the obstruction and address the acute ischemic process.
Prevention emphasizes cardiovascular risk-factor management rather than focusing only on the acute clot. Research in this area examines how controlling modifiable risks may reduce the likelihood of plaque-related thrombosis and subsequent acute coronary syndromes. This preventive perspective complements emergency evaluation and treatment by addressing factors that contribute to disease development.